ZYBERNO
Stock Report
Updated Sep 1, 2026

BRASKEM SA (BAK)

Materials • NYSE

$1.68

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
9.0/100
POOR BUSINESS
BRASKEM SA (BAK) scores 9/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (-2.4%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

BRASKEM SA (BAK) stock report — Zyberno Score 9/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:1.68
Market Cap:$3.20B

Valuation Multiples (1)

Peg Ratio:-999.00x

Enterprise Metrics (2)

Enterprise Value:$10.68B
Ev Ebitda Ratio:14.11x

Price Action & Momentum (3)

Momentum Percentile:19 / 100
% of 52-Week High:12.2%
B. Profitability Assessment

Return Metrics (3)

Reinvestment Rate:146.9%
Fundamental Growth Rate (g):-3.5%

Margin Analysis (1)

Ebitda Margin:5.0%

Yield Metrics (2)

Earnings Yield:-$999.00
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:1.31x
Quick Ratio:0.83x
Cash Ratio:0.53x

Leverage Analysis (1)

Debt To Ebitda:13.75x

Coverage Ratios (2)

Interest Coverage Ratio:-0.16x
Times Interest Earned:-0.16

Capital Structure (4)

Working Capital:1,713,496,145.00
Cash And Cash Equivalents:2,929,658,098.00
Long Term Debt:$9.96B
Net Debt:$7.48B
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

$15.13B
Cost Of Revenue Ttm:$13.96B

Profitability Breakdown (2)

$1.17B-$210.94M

Bottom Line Performance (3)

-$2.36B
Income Before Tax:$0.00
Ebitda Ttm:756,753,403.00

Operating Expenses (5)

Operating Expenses:0.00
R And D Expense:0.00
Sga Expense:0.00
Income Tax Expense:-$1.11B
Interest Expense:1,339,713,529.00

Expense Ratios (3)

R And D To Revenue Percentage:0.0%
Sga To Revenue Percentage:0.0%
Ebitda Margin:5.0%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$19.86B
Current Assets:$7.24B
Ppe Net:7,901,240,581.00
Goodwill:0.00
Intangible Assets:$662.13M

Liability Structure (4)

Total Liabilities:20,693,520,529.00
Current Liabilities:5,526,978,096.00
Long Term Debt:$9.96B
Short Term Debt:$445.33M

Equity & Capital (3)

Equity:-$836.32M
Retained Earnings:$0.00
Common Stock:0.00

Working Capital Items (3)

Accounts Receivable:0.00
Inventory:2,675,908,184.00
Accounts Payable:3,300,508,319.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:0.00
C. Cash Flow Analysis

Operating Activities (2)

$476.03M-$259.22M

Investment Activities (1)

Investing Cash Flow:-$681.29M

Financing Activities (3)

Financing Cash Flow:$91.69M
Dividends Paid Ttm:1,172,958.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (1)

Earnings Per Share Ttm:-$1.24

Revenue & Cash Per Share (2)

Sales Per Share Ttm:7.93
Operating Cash Flow Per Share:$0.25

Book Value & Capital (2)

Book Value Per Share:-$0.44
Cash Per Share:1.54

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.76x
Working Capital Turnover Ttm:8.83x

Receivables Management (2)

Receivables Turnover Ttm:-999.00x
Days Sales Outstanding Ttm:-999.00

Inventory Management (2)

Inventory Turnover Ttm:5.22x
Days Inventory Outstanding Ttm:69.96

Payables & Cash Cycle (2)

Days Payable Outstanding:86.29
Cash Conversion Cycle:-1,015.33
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:20.00
Quality Score:30.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Damodaran Growth Analysis (2)

Reinvestment Rate:146.9%
Fundamental Growth Rate (g):-3.5%
B. Log-Linear Regression Growth Analysis
C. Company Profile & Context

Corporate Information (6)

Symbol:BAK
Company Name:BRASKEM SA
Sector:Materials
Industry:Chemicals
Exchange:NYSE
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:low
Volume Category:N/A

Share Structure (3)

Shares Outstanding:1.91B
Shares Outstanding Basic:0
Shares Outstanding Diluted:0

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 09:56:09 UTC
Data Timestamp:2026-09-01T09:56:09.363649
Scroll to Top